Last $14.66 USD
Change Today 0.00 / 0.00%
Volume 14.8K
ROCM On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

rochester medical corp (ROCM) Snapshot

Open
$14.56
Previous Close
$14.66
Day High
$14.70
Day Low
$14.51
52 Week High
04/11/13 - $15.34
52 Week Low
11/13/12 - $9.11
Market Cap
180.9M
Average Volume 10 Days
28.0K
EPS TTM
$0.31
Shares Outstanding
12.3M
EX-Date
--
P/E TM
47.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for ROCHESTER MEDICAL CORP (ROCM)

Related News

No related news articles were found.

rochester medical corp (ROCM) Related Businessweek News

No Related Businessweek News Found

rochester medical corp (ROCM) Details

Rochester Medical Corporation engages in the development, manufacture, and marketing of PVC-free and latex-free urinary continence and urine drainage care products for the home and acute care markets. Its home care products include silicone male external catheters (MECs) under the UltraFlex, Pop-On, Wide Band, Natural, Clear Advantage, Transfix, and Spirit names for managing male urinary incontinence; latex MECs under the Freedom and Freedom Plus names for managing male urinary incontinence; intermittent catheters, such as standard, antibacterial, hydrophilic, and antibacterial personal catheters in various diameters for male, female, and pediatric use; and the FemSoft Insert, a liquid-filled urethral insert for managing stress urinary incontinence in adult females. The company’s acute care products comprise standard and StrataSI silicone Foley catheters, as well as StrataNF catheter, an antibacterial Foley catheter that reduces the incidence of hospital acquired urinary tract infection. It also distributes ostomy, and wound and scar care products and accessories; anti-decubitis mattresses; and other branded urological products. Rochester Medical Corporation offers its products to distributors, individual hospitals, healthcare institutions, and extended care facilities. The company markets its products primarily under the Rochester Medical brand name through a direct sales force in the United States, the United Kingdom, and the Netherlands; and supplies to various medical product companies and group purchasing organizations, as well as markets through independent distributors in other international markets. Rochester Medical Corporation was founded in 1988 and is headquartered in Stewartville, Minnesota.

344 Employees
Last Reported Date: 12/19/12
Founded in 1988

rochester medical corp (ROCM) Top Compensated Officers

Co-Founder, Executive Chairman, Chief Executi...
Total Annual Compensation: $306.9K
Co-Founder and Vice President of Production T...
Total Annual Compensation: $192.6K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $224.0K
Corporate Vice President
Total Annual Compensation: $209.4K
Vice President of Sales and Marketing
Total Annual Compensation: $172.5K
Compensation as of Fiscal Year 2012.

rochester medical corp (ROCM) Key Developments

Rochester Medical Corporation Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended March 31, 2013; Reaffirms Earnings Guidance for the Fiscal Year 2013

Rochester Medical Corporation announced unaudited consolidated earnings results for the second quarter and six months ended March 31, 2013. For the quarter, the company reported sales of $16,635,070 against $15,427,275 a year ago. Income from operations was $1,773,223 against $834,331 a year ago. Net income before income taxes was $1,723,142 against $884,113 a year ago. Net income was $1,199,250 or $0.10 per diluted share against $602,514 or $0.05 per diluted share a year ago. Non-GAAP net income was $1,488,250 or $0.12 per diluted share against $920,000 or $0.08 per diluted share a year ago. The 113% increase in GAAP operating income drove an incremental operating margin of 79% in the second quarter. For the six months period, the company reported sales of $33,887,078 against $29,399,882 a year ago. Income from operations was $3,150,727 against $813,602 a year ago. Net income before income taxes was $3,110,909 against $772,314 a year ago. Net income was $2,211,395 or $0.18 per diluted share against $527,167 or $0.04 per diluted share a year ago. Non-GAAP net income was $2,914,395 or $0.23 per diluted share against $1,204,000,000 or $0.10 per diluted share a year ago. The company reaffirms guidance for fiscal 2013, sales of approximately $67 million. This represents growth of approximately 17% year-over-year, excluding Foley sales in both periods. The company also reaffirms after-tax profit guidance of approximately $7 million.

Rochester Medical Corporation, Q2 2013 Earnings Call, Apr 25, 2013

Rochester Medical Corporation, Q2 2013 Earnings Call, Apr 25, 2013

Rochester Medical Corporation to Report Q2, 2013 Results on Apr 25, 2013

Rochester Medical Corporation announced that they will report Q2, 2013 results at 5:00 PM, Eastern Standard Time on Apr 25, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROCM:US $14.66 USD 0.00

ROCM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Coloplast A/S kr326.50 DKK -0.50
Covidien PLC $65.17 USD -0.04
CR Bard Inc $105.14 USD -0.01
Kimberly-Clark Corp $103.51 USD +0.97
Teleflex Inc $78.71 USD +0.41
View Industry Companies
 

Industry Analysis

ROCM

Industry Average

Valuation ROCM Industry Range
Price/Earnings 48.9x
Price/Sales 2.7x
Price/Book 2.6x
Price/Cash Flow 48.4x
TEV/Sales 2.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHESTER MEDICAL CORP, please visit www.rocm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.